{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T23:07:20Z","timestamp":1778800040749,"version":"3.51.4"},"reference-count":13,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:00:00Z","timestamp":1778803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Toxicol."],"DOI":"10.3389\/ftox.2026.1843194","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T22:10:11Z","timestamp":1778796611000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Editorial: Application of new approach methodologies in toxicological assessment of next-generation tobacco and nicotine products"],"prefix":"10.3389","volume":"8","author":[{"given":"Ranulfo","family":"Lemus","sequence":"first","affiliation":[{"name":"Letox World LLC","place":["Dayton, OH, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. Monica","family":"Lee","sequence":"additional","affiliation":[{"name":"Crestview Consultation LLC","place":["Manakin-Sabot, VA, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosalia","family":"Emma","sequence":"additional","affiliation":[{"name":"Department of Medicine and Surgery \u201cKore\u201d University of Enna","place":["Enna, Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Caruso","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Biotechnological Sciences, University of Catania","place":["Catania, Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M.","family":"Wood","sequence":"additional","affiliation":[{"name":"Clinical Toxicology, Guy\u2019s and St Thomas\u2019 NHS Foundation Trust, King\u2019s Health Partners and King\u2019s College London","place":["London, United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.yrtph.2018.04.018","article-title":"A big data approach to the concordance of the toxicity of pharmaceuticals in animals and humans","volume":"96","author":"Clark","year":"2018","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"B2","first-page":"10","article-title":"Directive 2010\/63\/EU of the european parliament and of the council of 22 September 2010 on the protection of animals used for scientific purposes","volume":"20","year":"2010","journal-title":"Official J. Eur. Union"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e200908","DOI":"10.2903\/j.efsa.2022.e200908","article-title":"The use of NAMs and omics data in risk assessment","volume":"20","author":"Berlin","year":"2022","journal-title":"EFSA J."},{"key":"B4","doi-asserted-by":"publisher","first-page":"760","DOI":"10.3390\/toxics10120760","article-title":"Advancing new approach methodologies (NAMs) for tobacco harm reduction: synopsis from the 2021 CORESTA SSPT-NAMs symposium","volume":"10","author":"Lee","year":"2022","journal-title":"Toxics"},{"key":"B5","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1089\/aivt.2016.0033","article-title":"Avoiding animal testing under the US family smoking prevention and tobacco control act","volume":"3","author":"Manuppello","year":"2017","journal-title":"Appl. Vitro Toxicol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.taap.2017.09.006","article-title":"Current nonclinical testing paradigm enables safe entry to first-in-human clinical trials: the IQ consortium nonclinical to clinical translational database","volume":"334","author":"Monticello","year":"2017","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"105904","DOI":"10.1016\/j.yrtph.2025.105904","article-title":"A call to action: advancing new approach methodologies (NAMs) in regulatory toxicology through a unified framework for validation and acceptance","volume":"162","author":"Ouedraogo","year":"2025","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"108082","DOI":"10.1016\/j.envint.2023.108082","article-title":"New approach methodologies in human regulatory toxicology - not if, but how and when","volume":"178","author":"Schmeisser","year":"2023","journal-title":"Environ. Int."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1376118","DOI":"10.3389\/ftox.2024.1376118","article-title":"Applying new approach methodologies to assess next-generation tobacco and nicotine products","volume":"6","author":"Thorne","year":"2024","journal-title":"Front. Toxicol."},{"key":"B10","article-title":"General considerations for the use of new approach methodologies in drug development","year":""},{"key":"B11","unstructured":"Roadmap to reducing animal testing in preclinical safety studies\n          \n          \n          2025"},{"key":"B12","article-title":"Roundtable on premarket tobacco product application (PMTA) submissions for electronic nicotine delivery systems (ENDS) products","year":"","journal-title":"Cent. Tob. Prod."},{"key":"B13","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1080\/09553002.2024.2442694","article-title":"Integration of multi-omics and benchmark dose modeling to support adverse outcome pathways","volume":"101","author":"Vuong","year":"2025","journal-title":"Int. J. Radiat. Biol."}],"container-title":["Frontiers in Toxicology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/ftox.2026.1843194\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T22:10:12Z","timestamp":1778796612000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/ftox.2026.1843194\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,15]]},"references-count":13,"alternative-id":["10.3389\/ftox.2026.1843194"],"URL":"https:\/\/doi.org\/10.3389\/ftox.2026.1843194","relation":{},"ISSN":["2673-3080"],"issn-type":[{"value":"2673-3080","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,15]]},"article-number":"1843194"}}